Fetal tachyarrhythmia - Current state of knowledge;Tachyarytmie u płodów - Aktualny stan wiedzy

Ginekologia Polska

Volumn 81, Issue 11, 2010, Pages 844-850

  Anita, Hamela Olkowska ^a   Joanna, Szymkiewicz Dangel ^a  

^a MEDICAL UNIVERSITY OF WARSAW   (Poland)

Author keywords

Fetal; Fetal echocardiography; Fetal tachyarrhythmia; Prenatal diagnosis

Indexed keywords

EID: 78650448309     PISSN: 00170011     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (66)

1. Hyman A. Irregularities of the fetal heart: a phonocardiografic study of the fetal heart sounds from the fifth to eight months of pregnancy. Am J Obstet Gynecol. 1930, 20, 332-347.
2. Silber D, Durnin R. Intrauterine atrial tachycardia associated with massive edema in a newborn. Am J Dis Child. 1969, 117, 722-726.
3. Respondek-Liberska M, Szymkiewicz-Dangel J, Tobota Z, i wsp. Założenia i wste{ogonek}pne wnioski Ogólnopolskiego Rejestru Patologii Kardiologicznych Płodów. Polski Przegla{ogonek}d Kardiol. 2008, 10, 129-135.
4. Krzysztolik-Ładzińska J, Włoch A, Szydłowski L, i wsp. Tachyarytmie w okresie płodowym -diagnostyka, poste{ogonek}powanie i leczenie. Post Neonatol. 2004, Supl 2, 126-130.
5. Lingman G, Ohrlander S, Ohlin P. Intrauterine digoxin treatment of fetal paroxysmal tachycardia - case report. Br J Obstet Gynecol. 1980, 87, 340-342.
6. Wolff F, Breuker K, Schlensker A, [et al.]. Prenatal diagnosis and theraphy of fetal heart anomalies with a contribution on the placental transfer of verapamil. J Perinat Med. 1980, 8, 203-208.
7. Teuscher A, Bossi E, Imhof P, [et al.]. Effect of propranolol on fetal tachycardia in diabetic pregnancy. Am J Cardiol. 1978, 42, 304-307.
8. Jaeggi E, Masaki N. Fetal brady- and tachyarrhythmias: new and accepted diagnostic and treatment methods. Sem Fetal Neonat Med. 2005, 10, 504-514.
9. Szymkiewicz-Dangel J, Hamela-Olkowska A, Bieganowska K, i wsp. Zaburzenia rytmu serca zagrażaja{ogonek}ce życiu płodu - diagnostyka i leczenie. Ginekol Pol. 2004, 75, Suppl 1, 385-390.
10. Simpson J, Sharland G. Fetal tachycardias: management and outcome of 127 consecutive cases. Heart. 1998, 79, 576-581.
11. Krapp M, Kohl T, Simpson J, [et al.]. Review of diagnosis, treatment and outcome of fetal atrial flutter compared with supraventricular tachycardia. Heart 2003, 89, 913-917.
12. Simpson J. Fetal arrhythmias. In Textbook of fetal cardiology. Ed. Allan L, Hornberger L, Sharland G. London: Greenwich Medical Media. 2000, 423-437.
13. Perles Z, Gavri S, Rein A. Tachyarrhythmias in the fetus: state of the art diagnosis and treatment. Prog Ped Cardiol. 2006, 22, 95-107.
14. Jaeggi E, Fouron J, Fournier A, [et al.]. Ventriculo-atrial time interval measured on M mode echocardiography: a determining element in diagnosis, treatment and prognosis of fetal supraventricular tachycardia. Heart. 1998, 79, 582-587.
15. Porat S, Anteby E, Hamani Y, [et al.]. Fetal supraventricular tachycardia diagnosed and treated at 13 weeks of gestation: a case report. Ultrasound Obstet Gynecol. 2003, 21, 302-305.
16. Oudijk M, Michon M, Kleinman C, [et al.]. Sotalol in the treatment of fetal dysrhythmias. Circulation. 2000, 101, 2721-2726.
17. Re{ogonek}kawek J. Nadkomorowe zaburzenia rytmu. W: Zaburzenia rytmu serca u dzieci. Red. Kubicka K, Bieganowska K. Warszawa: PZWL. 2001, 101-134.
18. Gembruch U. Fetal tachyarrhythmia. In: Fetal cardiology. Ed. Yagel S, Silverman N, Gembruch U. London: Martin Dunitz. 2003, 355-371.
19. Van Kamp I, Klumper F, Bakkum R, [et al.]. The severity of immune fetal hydrops is predictive of fetal outcome after intrauterine treatment. Am J Obstet Gynecol. 2001, 185, 688-673.
20. Strasburger J. Fetal arrhythmias. Prog Ped Cardiol. 2000, 11, 1-17.
21. Juneja R, Shah S, Naik N, [et al.]. Management of cardiomyopathy resulting from incessant supraventricular tachycardia in infants and children. Indian Heart J. 2002, 54, 176-180.
22. Gembruch U, Redel D, Bald R, [et al.]. Longitudinal study in 18 cases of fetal supraventricular tachycardia: Doppler echocardiographic findings and pathophysiologic implications. Am Heart J. 1993, 125, 1290-1301.
23. Van Doornik M, Cats B, Barth P, [et al.]. Intra-uterine tachycardia associated with multicystic encephalomalacia (MCE). Eur J Obstet Gynecol Reprod Biol. 1985, 20, 191-195.
24. Sonesson S, Winberg P, Lidegran M, [et al.]. Foetal supraventricular tachycardia and cerebral complications. Acta Paediatr. 1996, 85, 1249-1252.
25. Szymkiewicz-Dangel J. Ocena przydatności badań echokardiograficznych płodów w perinatologii. Rozprawa habilitacyjna. Warszawa: Dział Wydawnictw Akademii Medycznej. 2004, 166-191.
26. Jaeggi E, Fouron J, Drblik S. Fetal atrial flutter: diagnosis, clinical features, treatment and outcome. J Pediatr. 1998, 132, 335-339.
27. Yoo S, Jaeggi E. Ultrasound evaluation of the fetal heart. In: Ultrasonography in obstetrics and gynecology. 5th Edition. Ed. Callen P. Philadelphia: Saunders Elsevier. 2008, 511-586.
28. Fouron J. Fetal arrhythmias: the Saint-Justine hospital experience. Prenat Diagn. 2004, 24, 1068-1080.
29. Parilla B, Strasburger J, Sokol M. Fetal supraventricular tachycardia complicated by hydrops fetalis: a role for direct fetal intramuscular therapy. Am J Perinatol. 1996, 13, 483-486.
30. Kleinman C, Copel J. Direct fetal therapy for cardiac arrhythmias: who, what, when, where, why and how? Ultrasound Obstet Gynecol. 1991, 1, 158-160.
31. Dangel J, Roszkowski T, Bieganowska K, [et al.] Adenosine triphosphate for cardioversion of supraventricular tachycardia in two hydropic fetuses. Fetal Diag Ther. 2000, 15, 326-330.
32. Fouron J, Proulx F, Miro J, [et al.]. Doppler and M-mode ultrasonography to time fetal atrial and ventricular contractions. Obstet Gynecol. 2000, 96, 732-736.
33. Aktualny stan wiedzy na temat terapii prenatalnej. Stanowisko grupy ekspertów PTG. W: Rekomendacje Polskiego Towarzystwa Ginekologicznego 2003-2007. Ginekologia po Dyplomie. 2008, Wydanie specjalne. 108-141.
34. Herman Z. Leki o działaniu inotropowo dodatnim. W: Farmakologia. Podstawy farmakoterapii. Red. Kostowski W. Warszawa: PZWL. 1998, 542-551.
35. Azancot-Benisty A, Jacqz-Aigrain E, Guirgis N, [et al.]. Clinical and pharmacologic study of fetal supraventricular tachyarrhythmias. J Pediatr. 1992, 121, 608-613.
36. Younis J, Granat M. Insufficient transplacental digoxin transfer in severe hydrops fetalis. Am J Obstet Gynecol. 1987, 157, 1268-1269.
37. King C, Mattioli L, Goertz K, [et al.]. Successful treatment of fetal supraventricular tachycardia with maternal digoxin therapy. Chest. 1984, 85, 573-575.
38. Walczak F. Zasady farmakologicznego leczenia zaburzeń rytmu serca. W: Farmakologia. Podstawy farmakoterapii. Red. Kostowski W. Warszawa: PZWL. 1998, 1309-1337.
39. Strasburger J, Cuneo B, Michon M, [et al.]. Amiodarone therapy for drug-refractory fetal tachycardia. Circulation. 2004, 109, 375-379.
40. Ito S, Magee L, Smallhorn J. Drug therapy for fetal arrhythmias. Clin Perinatol. 1994, 21, 543-572.
41. Mangione R, Guyon F, Vergnaud A, [et al.]. Successful treatment of refractory supraventricular tachycardia by repeat intravascular injection of amiodarone in a fetus with hydrops. Eur J Obstet Gynecol Reprod Biol. 1999, 86, 105-107.
42. Filipiak K, Jasik M, Opolski G. Właściwości farmakokinetyczne amiodaronu. W: Amiodaron. Miejsce we współczesnej terapii zaburzeń rytmu serca. Red. Kosior D, Opolski G. Warszawa: Remedy. 2003, 12-19.
43. Perry J, Fenrich A Jr, Hulse J, [et al.]. Pediatric use of intravenous amiodarone: efficacy and safety in critically ill patients from a multicenter protocol. J Am Coll Cardiol. 1996, 27, 1246-1250.
44. De Catte L, De Wolf D, Smitz J, [et al.]. Fetal hypothyroidism as a complication of amiodarone treatment for persistent fetal supraventricular tachycardia. Prenat Diagn. 1994, 14, 762-765.
45. Widerhorn J, Bhandari A, Bughi S, [et al.]. Fetal and neonatal adverse effects profile of amiodarone treatment during pregnancy. Am Heart J. 1991, 122, 1162-1166.
46. Ovadia M, Brito M, Hoyer G, [et al.]. Human experience with amiodarone in the embryonic period. Am J Cardiol. 1994, 73, 316-317.
47. Oudijk M, Ruskamp J, Ververs F, [et al.]. Treatment of fetal tachycardia with sotalol: transplacental pharmacokinetics and pharmacodynamics. J Am Coll Cardiol. 2003, 42, 765-770.
48. Sonesson S, Fouron J, Wesslen-Eriksson, [et al.]. Foetal supraventricular tachycardia treated with sotalol. Acta Paediatr. 1998, 87, 584-587.
49. D'Alto M, Russo M, Paladini D, [et al.] The challenge of fetal dysrhythmias: echocardiographic diagnosis and clinical management. J Cardiovasc Med. 2008, 9, 153-160.
50. Allan L, Chita S, Sharland G, [et al.]. Flecainide in the treatment of fetal tachycardias. Br Heart J. 1991, 65, 46-48.
51. Perry J, Ayres N, Carpenter R. Fetal supraventricular tachycardia treated with flecainide acetate. J Pediatr. 1991, 118, 303-305.
52. Respondek-Liberska M, Jarosik K, Janiak K, i wsp. Losy płodów z tachyarytmiami >200/min - łódzkie badania dwuośrodkowe. Polski Przegla{ogonek}d Kardiologiczny. 2006, 8, 35-39.
53. Herman Z. Leki przeciwarytmiczne. W: Farmakologia. Podstawy farmakoterapii. Red. Kostowski W. Warszawa: PZWL. 1998, 524-541.
54. Oudijk M, Ruskamp J, Ambachtsheer B. Drug treatment of fetal tachycardias. Pediatr Drugs. 2002, 4, 49-63.
55. Lilja H, Karlsson K, Lindecrantz K, [et al.]. Treatment of intrauterine supraventricular tachycardia with digoxin and verapamil. J Perinat Med. 1984, 12, 151-154.
56. Owen J, Colvin E, Davis R. Fetal death after successful conversion of fetal supraventricular tachycardia with digoxin and verapamil. Am J Obstet Gynecol. 1988, 158, 1169-1170.
57. Van Engelen A, Weijtens O, Brenner J, [et al.]. Management outcome and follow-up of fetal tachycardia. J Am Coll Cardiol. 1994, 24, 1371-1375.
58. Simpson J, Milburn A, Yates R, [et al.]. Outcome of intermittent tachyarrhythmias in the fetus. Pediatr Cardiol. 1997, 18, 78-82.
59. Jouannic J, Delahaye S, Fermont L, [et al.]. Fetal supraventricular tachycardia: a role for amiodarone as second-line therapy? Prenat Diagn. 2003, 23, 152-156.
60. Hamela-Olkowska A. Diagnostyka i terapia zaburzeń przewodzenia i rytmu serca u płodów. Rozprawa na stopień doktora nauk medycznych. Warszawa: Warszawski Uniwersytet Medyczny, 2010.
61. Frohn-Mulder I, Stewart P, Witsenburg M, [et al.]. The efficacy of flecainide versus digoxin in the management of fetal supraventricular tachycardia. Prenat Diagn. 1995, 15, 1297-1302.
62. Colin A, Chabaud J, Poinsot J, [et al.]. Fetal supraventricular tachycardias and their treatment. Apropos of 23 cases. Arch Fr Pediatr. 1989, 46, 335-340.
63. Lopriore E, Aziz M, Nagel H, [et al.]. Long-term neurodevelopmental outcome after fetal arrhythmia. Am J Obstet Gynecol. 2009, 201, 1-5.
64. Maeno Y, Hirose A, Kanbe T, [et al.]. Fetal arrhythmia: prenatal diagnosis and perinatal management. J Obstet Gynaecol Res. 2009, 35, 623-629.
65. Wren C. Mechanisms of fetal tachycardia. Heart. 1998, 79, 536-537.
66. Lulić Jurjević R, Podnar T, Vesel S. Diagnosis, clinical features, management, and post-natal follow-up of fetal tachycardias. Cardiol Young. 2009, 19, 486-493.